In our investigation, we initiated by analyzing the correlation between GATA6 expression levels and clinical parameters in lung cancer samples, revealing that both mRNA and protein levels of GATA6 were diminished in lung adenocarcinoma tissues relative to normal lung tissues. The gene discussed is GATA6; the disease is lung adenocarcinoma.